Septerna, Other Current Liab from 2010 to 2024

SEPN Stock   25.29  0.51  2.06%   
Septerna, Common Other Current Liabilities yearly trend continues to be very stable with very little volatility. Other Current Liabilities is likely to drop to about 74.2 K. During the period from 2010 to 2024, Septerna, Common Other Current Liabilities quarterly data regression pattern had sample variance of 112.8 M and median of  50,000. View All Fundamentals
 
Other Current Liabilities  
First Reported
2010-12-31
Previous Quarter
85 K
Current Value
74.2 K
Quarterly Volatility
10.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Septerna, Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Septerna, Common's main balance sheet or income statement drivers, such as Tax Provision of 380.1 K, Net Interest Income of 1.7 M or Interest Income of 1.7 M, as well as many indicators such as . Septerna, financial statements analysis is a perfect complement when working with Septerna, Common Valuation or Volatility modules.
  
Check out the analysis of Septerna, Common Correlation against competitors.

Pair Trading with Septerna, Common

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Septerna, Common position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Septerna, Common will appreciate offsetting losses from the drop in the long position's value.

Moving against Septerna, Stock

  0.6FRTX Fresh Tracks TherapeuticsPairCorr
The ability to find closely correlated positions to Septerna, Common could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Septerna, Common when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Septerna, Common - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Septerna, Common Stock to buy it.
The correlation of Septerna, Common is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Septerna, Common moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Septerna, Common Stock moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Septerna, Common can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Septerna, Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Septerna, Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Septerna, Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Septerna, Common Stock Stock:
Check out the analysis of Septerna, Common Correlation against competitors.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Septerna, Common. If investors know Septerna, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Septerna, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Septerna, Common Stock is measured differently than its book value, which is the value of Septerna, that is recorded on the company's balance sheet. Investors also form their own opinion of Septerna, Common's value that differs from its market value or its book value, called intrinsic value, which is Septerna, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Septerna, Common's market value can be influenced by many factors that don't directly affect Septerna, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Septerna, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Septerna, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Septerna, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.